Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

被引:313
作者
Mahley, RW
Huang, YD
机构
[1] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
D O I
10.1097/00041433-199906000-00003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein E is a key regulator of plasma lipid levels. Our appreciation of its role continues to expand as additional aspects of its function are discovered. Apolipoprotein E affects the levels of all lipoproteins, either directly or indirectly by modulating their receptor-mediated clearance or lipolytic processing and the production of hepatic very low density lipoproteins. Furthermore, it plays a critical role in neurobiology. The apolipoprotein E4 allele is the major susceptibility gene related to the occurrence and early age of onset of Alzheimer's disease. It is probable that one of the major functions of apolipoprotein E in the central nervous system is to mediate neuronal repair, remodeling, and protection, with apolipoprotein E4 being less effective than the E3 and E2 alleles. The isoform-specific effects of apolipoprotein E are currently being unraveled through detailed structure and function studies of this protein. Curr Opin Lipidol 10:207-217. (C) 1999 Lippincott Wiiliams & Wilkins.
引用
收藏
页码:207 / 217
页数:11
相关论文
共 100 条
  • [71] RALL SC, 1982, J BIOL CHEM, V257, P4171
  • [72] REBECK GW, 1993, NEURON, V11, P575
  • [73] Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo
    Rensen, PCN
    vanBerkel, TJC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) : 14791 - 14799
  • [74] Apolipoprotein E alleles as risk factors in Alzheimer's disease
    Roses, AD
    [J]. ANNUAL REVIEW OF MEDICINE, 1996, 47 : 387 - 400
  • [75] Salah D, 1997, J LIPID RES, V38, P904
  • [76] APOLIPOPROTEIN-E ASSOCIATES WITH BETA-AMYLOID PEPTIDE OF ALZHEIMERS-DISEASE TO FORM NOVEL MONOFIBRILS - ISOFORM APOE4 ASSOCIATES MORE EFFICIENTLY THAN APOE3
    SANAN, DA
    WEISGRABER, KH
    RUSSELL, SJ
    MAHLEY, RW
    HUANG, D
    SAUNDERS, A
    SCHMECHEL, D
    WISNIEWSKI, T
    FRANGIONE, B
    ROSES, AD
    STRITTMATTER, WJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) : 860 - 869
  • [77] FAMILIAL DYSBETALIPOPROTEINEMIA - ABNORMAL BINDING OF MUTANT APOPROTEIN-E TO LOW-DENSITY LIPOPROTEIN RECEPTORS OF HUMAN-FIBROBLASTS AND MEMBRANES FROM LIVER AND ADRENAL OF RATS, RABBITS, AND COWS
    SCHNEIDER, WJ
    KOVANEN, PT
    BROWN, MS
    GOLDSTEIN, JL
    UTERMANN, G
    WEBER, W
    HAVEL, RJ
    KOTITE, L
    KANE, JP
    INNERARITY, TL
    MAHLEY, RW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) : 1075 - 1085
  • [78] Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice
    Sheng, HX
    Laskowitz, DT
    Bennett, E
    Schmechel, DE
    Bart, RD
    Saunders, AM
    Pearlstein, RD
    Roses, AD
    Warner, DS
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (04) : 361 - 366
  • [79] SHERRILL BC, 1980, J BIOL CHEM, V255, P1804
  • [80] HETEROGENEITY OF HUMAN PLASMA VERY LOW-DENSITY LIPOPROTEINS - SEPARATION OF SPECIES DIFFERING IN PROTEIN COMPONENTS
    SHORE, VG
    SHORE, B
    [J]. BIOCHEMISTRY, 1973, 12 (03) : 502 - 507